Not Available
biswas_07pharm@ru.ac.bd; mohitosh.biswas2015@gmail.com
Professor, Department of Pharmacy, University of Rajshahi
Dr. Mohitosh Biswas
PROFESSOR
Pharmacy
- Education Summary
- BPharm (1st Class 1st, RU ); MPharm (1st Class 1st, RU); PhD (The University of Newcastle, Australia)
- Research Interest
- Pharmacogenomics, Precision Medicine
| Level | Institution | Year |
|---|---|---|
| Doctoral (PhD) |
The University of Newcastle, Australia | 2018 |
| Masters (MPharm) |
Rajshahi University | 2007 |
| Bachelor/Honors (BPharm) |
Rajshahi University | 2006 |
Experience in Rajshahi University
| Duration | Organization/Institute | Position |
|---|---|---|
| 2024-09-24 to | Department of Pharmacy | PROFESSOR |
| 2019-05-05 to 2024-09-23 | Department of Pharmacy | ASSOCIATE PROFESSOR |
| 2014-07-12 to 2019-05-04 | Department of Pharmacy | ASSISTANT PROFESSOR |
| 2012-09-23 to 2014-07-11 | Department of Pharmacy | LECTURER |
Experience in other Organization/Institute
Not Available
Journal
| 1. |
Biswas M, Hossain MS, Ahmed Rupok T, Hossain MS, Sukasem C
"The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis"
Clinical & Translational Science,17(4):e13792. doi: 10.1111/cts.13792
Published: April 2024
|
| 2. |
Sornsamdang G, Satapornpong P, Jinda P, Jantararoungtong T, Koomdee N, Tempark T, Klaewsongkram J, Rerkpattanapipat T, Rerknimitr P, Tuchinda P, Chularojanamontri L, Tovanabutra N, Chanprapaph K, Disphanurat W, Chakkavittumrong P, Srisuttiyakorn C, Sri
"Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients"
BMC Medical Genomics,17(1):101. doi: 10.1186/s12920-024-01874-y
Published: April 2024
|
| 3. |
Choochuay K, Kunhapan P, Puangpetch A, Tongsima S, Srisawasdi P, Sobhonslidsuk A, Sungkanuparph S, Biswas M, Sukasem C
"Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus"
World Journal of Hepatology,16(3):366-378. doi: 10.4254/wjh.v16.i3.366
Published: March 2024
|
| 4. |
Biswas M, Vanwong N, Sukasem C
"Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications"
Frontiers in Pharmacology,14:1285967. doi: 10.3389/fphar.2023.1285967
Published: March 2024
|
| 5. |
Chaemsaithong P, Biswas M, Lertrut W, Warintaksa P, Wataganara T, Poon LCY, Sukasem C
"Pharmacogenomics of Preeclampsia therapies: Current evidence and future challenges for clinical implementation"
Best Practice & Research Clinical Obstetrics & Gynaecology,92:102437. doi: 10.1016/j.bpobgyn.2023.102437
Published: March 2024
|
| 6. |
Biswas M and Sukasem C
"Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications"
Pharmacogenomics,24(15):831-840. doi: 10.2217/pgs-2023-0124.
Published: October 2023
|
| 7. |
Biswas M, Kali MSK, Sarker A, Sukasem C
"Association of Q192R PON1 genetic polymorphism with major adverse cardiovascular events in patients treated with clopidogrel: An updated meta-analysis"
Expert Opinion on Drug Safety,22(9):807-817. doi: 10.1080/14740338.2023.2212152
Published: July 2023
|
| 8. |
Sukasem C, Biswas M, Lungchukiet P, Sangtian M
"Clinical pharmacogenomics implementation in Thailand: a dream come true"
Pharmacogenomics,24(6):297-301. doi: 10.2217/pgs-2023-0071
Published: April 2023
|
| 9. |
Biswas M, John S, Jinda P, Sukasem C
"Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine"
Expert Opinion on Drug Metabolism & Toxicology,19(3):165-174. doi: 10.1080/17425255.2023.2203860
Published: March 2023
|
| 10. |
Biswas M, Jinda P, Sukasem C
"Pharmacogenomics in Asians: differences and similarities with other human populations"
Expert Opinion on Drug Metabolism & Toxicology,19(1):27-41. doi: 10.1080/17425255.2023.2178895
Published: January 2023
|
| 11. |
Roy DN, Azam MS, Biswas M, Islam E
"Potential factors influencing COVID-19 vaccine acceptance and hesitancy among university students in Bangladesh: A cross-sectional comparative study"
Epidemiology & Infection,1–20. doi: 10.1017/S0950268822001820
Published: December 2022
|
| 12. |
Biswas M
"Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19"
Archives of Immunology Research and Therapy,1(2):2-6.
Published: December 2022
|
| 13. |
Roy DN, Hossen MM, Biswas M, Islam E, Azam MS
"Factors influencing COVID-19 vaccine acceptance and hesitancy among pharmacy students in Bangladesh: a cross-sectional study"
F1000Research,11:1379. doi:10.12688/f1000research.126560.1
Published: November 2022
|
| 14. |
Roy DN, Hossen MM, Biswas M, Islam E, Azam MS
"Prevalence of COVID-19 vaccine hesitancy in students: A global systematic review"
F1000Research,11:928. doi: 10.12688/f1000research.122815.1
Published: August 2022
|
| 15. |
Biswas M, Ershadian M, John S, Sukasem C
"Associations of HLA genetic variants with carbamazepine induced cutaneous adverse drug reactions: An updated meta-analysis"
Clinical & Translational Science,15(8):1887-1905. doi: 10.1111/cts.13291
Published: August 2022
|
| 16. |
Tiwattanon K, John S, Koomdee N, Jinda P, Rachanakul J, Jantararoungtong T, Nuntharadthanaphong N, Kloypan C, Biswas M, Boongird A, Sukasem C
"Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand"
Frontiers in Pharmacology,13:867490. doi: 10.3389/fphar.2022.867490
Published: July 2022
|
| 17. |
Atasilp C, Biswas M, Jinda P, Nuntharadthanaphong N, Rachanakul J, Hongkaew Y, Vanwong N, Saokaew S, Sukasem C
"Association of UGT1A1*6,*28 or ABCC2 c.3972C>T genetic polymorphisms with irinotecan induced toxicity in Asian cancer patients: Meta-analysis"
Clinical & Translational Science,15(7):1613-1633. doi: 10.1111/cts.13277
Published: July 2022
|
| 18. |
Biswas M, Vanwong N, Sukasem C
"Pharmacogenomics in clinical practice to prevent Risperidone-induced hyperprolactinemia in Autism spectrum disorder"
Pharmacogenomics,23(8):493-503. doi: 10.2217/pgs-2022-0016
Published: June 2022
|
| 19. |
Koomdee N, Kloypan C, Jinda P, Rachanakul J, Jantararoungtong T, Sukprasong R, Prommas S, Nuntharadthanaphong N, Puangpetch A, Ershadian M, John S, Biswas M, Sukasem C
"Evolution of HLA-B pharmacogenomics and the importance of PGx data integration in health care system: A 10-year retrospective study in Thailand"
Frontiers in Pharmacology,13:866903. doi: 10.3389/fphar.2022.866903.
Published: April 2022
|
| 20. |
Roy DN, Biswas M, Islam E, Azam MS
"Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review"
PLoS One,17(3):e0265496. doi: 10.1371/journal.pone.0265496. eCollection 2022
Published: March 2022
|
| 21. |
Biswas M, Sawajan N, Rungrotmongkol T, Sanachai K, Ershadian M, Sukasem C
"Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies"
Frontiers in Pharmacology,13:835136. doi: 10.3389/fphar.2022.835136
Published: March 2022
|
| 22. |
Biswas M, Sukasem C, Khatun Kali MS, Ibrahim B
"Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis"
Pharmacogenomics,23(3):207-220. doi: 10.2217/pgs-2021-0098
Published: March 2022
|
| 23. |
Nguyen AH, Biswas M, Puangpetch A, Prommas S, Pakakasama S, Anurathapan U, Rachanakul J, Sukprasong R, Nuntharadtanaphong N, Jongjitsook N, Hongeng S, Sukasem C
"Effect of GSTA1 Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians"
Pharmaceutics,14(2):401. doi: 10.3390/pharmaceutics14020401
Published: March 2022
|
| 24. |
Biswas M and Kali SK.
"Association of CYP2C19 loss-of-function alleles with major adverse cardiovascular events of clopidogrel in stable coronary artery disease patients undergoing percutaneous coronary intervention: Meta-analysis"
Cardiovascular Drugs and Therapy,35(6):1147-1159. doi: 10.1007/s10557-021-07142-w
Published: December 2021
|
| 25. |
Biswas M and Roy DN.
"Potential clinically significant drug–drug interactions of hydroxychloroquine used in the treatment of COVID-19"
International Journal of Clinical Practice,75(11):e14710. doi: 10.1111/ijcp.14710
Published: November 2021
|
| 26. |
Kloypan C, Koomdee N, Satapornpong P, Tempark T, Biswas M, Sukasem C
"A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine"
Pharmaceuticals,14(11):1077.doi: 10.3390/ph14111077
Published: October 2021
|
| 27. |
Biswas M, Rahaman S, Biswas TK, Ibrahim B
"Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis"
International Journal of Clinical Pharmacy,43(5):1360-1369. doi: 10.1007/s11096-021-01261-y
Published: October 2021
|
| 28. |
Biswas M, Kali MSK, Biswas TK, Ibrahim B
"Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis"
Platelets,32(5):591-600: doi: 10.1080/09537104.2020.1792871
Published: July 2021
|
| 29. |
Biswas M
"Predictive Prevalence of Risk Phenotypes Associated With rs2285666 Single Nucleotide Polymorphism of ACE2 in the World Population Susceptible to SARS-CoV-2 Infection"
Journal of Virology Research & Reports,2(2):1-4
Published: June 2021
|
| 30. |
Biswas M
"Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients"
Pharmacogenomics,10.2217/pgs-2020-0096. doi: 10.2217/pgs-2020-0096
Published: April 2021
|
| 31. |
Biswas M
"Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications."
The Pharmacogenomics Journal,21(2):190-199. doi:10.1038/s41397-020-00196-3
Published: April 2021
|
| 32. |
Biswas M and Kali SK
"Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis."
Scientific Reports,11(1):5012. doi: 10.1038/s41598-021-84678-9
Published: March 2021
|
| 33. |
Biswas M, Rahaman S, Biswas TK, Ibrahim B
"Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic revie"
Expert Opinion on Drug safety,19(12); 1605-1616. doi: 10.1080/14740338.2020.1836152
Published: December 2020
|
| 34. |
Biswas M, Rahman S, Biswas TK, Haque Z, Ibrahim B
"Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis"
Intervirology,1-12. doi: 10.1159/000512592
Published: December 2020
|
| 35. |
Biswas M
"Potential clinically significant life-threatening drug–drug interactions of lopinavir and ritonavir used in the treatment of COVID-19"
Experimental Results,1(e49):1-9. doi: 10.1017/exp.2020.53
Published: October 2020
|
| 36. |
Biswas M, Dias TH, Eftekhari P, et al.
"Precision Medicine and biomarker profiling in pharmacy practice"
Australian Pharmacist,38(5); 46-51
Published: June 2019
|
| 37. |
Eftekhari P, Dias TH, Biswas M, et al.
"Update on genetic testing services in pharmacy practice"
Australian Pharmacist,38(1); 60-66
Published: March 2019
|
| 38. |
Chouduri AU, Biswas M, Haque MU, et al.
"Cephalosporin-3G, Highly Prescribed Antibiotic to Outpatients in Rajshahi, Bangladesh: Prescription Errors, Carelessness, Irrational Uses are the Triggering Causes of Antibiotic Resistance"
Journal of Applied Pharmaceutical Science,8(06); 105-112.
Published: June 2018
|
| 39. |
Biswas M, Dias TH, Daneshi N, et al.
"Potential simple and multifactorial drug-gene interactions of tricyclic antidepressants in older Australians"
Journal of Advances in Medical Research,2(1); 1-14.
Published: December 2017
|
| 40. |
Dias TH, Biswas M, Maguire J, et al.
"Pharmacogenomics of pain drugs used in palliative care"
Australian Pharmacist,36(12); 50-53
Published: December 2017
|
| 41. |
Gollan M, Biswas M, Dias TH, et al.
"New gene-based treatments for cystic fibrosis from next generation personalised precision medicine"
Australian Pharmacist,36(11); 40-43
Published: November 2017
|
| 42. |
Fossouo-Tagne J, Biswas M, Dias TH, et al.
"An introduction to the pharmacogenomics of oncology drugs"
Australian Pharmacist,36(9); 44-47.
Published: September 2017
|
| 43. |
Biswas M, Dias TH, Daneshi N, et al.
"Pharmacogenomics of cardiovascular drugs"
Australian Pharmacist,36(7); 50-53
Published: July 2017
|
| 44. |
Dias TH, Sayer T, Daneshi N, Biswas M, et al.
"Pharmacogenomics of rheumatoid arthritis"
Australian Pharmacist,36(3); 45-49.
Published: March 2017
|
| 45. |
Daneshi N, Sayer T, Biswas M, et al.
"An update on antidepressant pharmacogenomics"
Australian Pharmacist,34(10); 60-64.
Published: October 2015
|
| 46. |
Rahman MM, Islam MB, Biswas M, et al.
"In vitro antioxidant and free radical scavenging activity of different parts of Tabebuia pallida growing in Bangladesh."
BMC Res Notes,8; 621. doi: 10.1186/s13104-015-1618-6
Published: October 2015
|
| 47. |
Daneshi N, Graham M, Biswas M, et al.
"Gene Scene, Health’s New Frontier"
Australian Pharmacist,34(5); 26-30
Published: May 2015
|
| 48. |
Biswas M, Roy DN, Rahman MM, et al.
"Doctor’s prescribing trends of antibiotics for outpatients in Bangladesh: A cross sectional health survey conducted in three cities of Bangladesh"
International Journal of Pharmaceutical Sciences and Research,69(2); 669-675
Published: February 2015
|
| 49. |
Biswas M, Roy MN, Manik MIN et al.
"Self medicated antibiotics in Bangladesh: a cross-sectional health survey conducted in the Rajshahi city"
BMC Public Health,14; 847. doi: 10.1186/1471-2458-14-847
Published: August 2014
|
| 50. |
Paul TR, Rahman MA, Biswas M, et al.
"Practice of Hospital Pharmacy in Bangladesh: Current Perspective"
Bangladesh Pharmaceutical Journal,17 (2); 187-192.
Published: July 2014
|
| 51. |
Biswas M, Roy DN, Islam M, et al.
"Prevalence and nature of handwritten outpatients prescription errors in Bangladesh"
International Journal of Pharmacy and Pharmaceutical Sciences,6(5); 126-130
Published: May 2014
|
| 52. |
Biswas M, Roy DN, Tajmim A, et al.
"Prescription antibiotics for outpatients in Bangladesh: A cross-sectional health survey conducted in three cities"
Annals of Clinical Microbiology and Antimicrobials,13; 15. doi: 10.1186/1476-0711-13-15
Published: April 2014
|
| 53. |
Paul TR, Rahman MA, Biswas M, et al.
"Medication errors in a private hospital of Bangladesh"
Bangladesh Pharmaceutical Journal,17 (1); 32-37
Published: January 2014
|
| 54. |
Biswas M, Roy DN, Rahman MM, et al.
"Medicinal plants for snake bite and sexual dysfunction in Jessore and Bagerhat districts of Bangladesh"
International Journal of Medicinal and Aromatic Plants,3(4); 486-491
Published: December 2013
|
| 55. |
Biswas M, Rahman MA, Kahtun MH et al.
"In-vitro antibacterial and cytotoxic activities of two compounds isolated from Streptomyces sp MBS-15"
Bangladesh Pharmaceutical Journal,15(1); 13-16
Published: January 2012
|
| 56. |
Kahtun MH, Rahman MA, Biswas M, et al.
"Water soluble fraction of Abelmoschus esculentus L interacts with glucose and metformin hydrochloride and alters their absorption kinetics after coadministration in rats"
International Scholarly Research Network (ISRN) Pharmaceutics,2011:260537. doi: 10.5402/2011/260537
Published: September 2011
|
| 57. |
Biswas M, Rahman MA, Kahtun MH et al.
"Isolation and characterization of Streptomyces sp ANBS-15 and antimicrobial activities of its secondary metabolites"
Bangladesh Pharmaceutical Journal,14(1); 15-20
Published: January 2011
|
| 58. |
Kahtun MH, Rahman MA, Biswas M, et al.
"In vitro study of the effects of viscous soluble dietary fibers of Abelmoschus esculentus L in lowering intestinal glucose absorption"
Bangladesh Pharmaceutical Journal,13(2); 35-40
Published: July 2010
|
Conference
| 1. |
Biswas M, Ershadian M and Sumasem C
"Association of CYP2C9*2,*3 or VKORC1 c.−1639 G>A genetic variants with bleeding toxicity in patients taking warfarin: Meta-analysis"
32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), Bangkok, Thailand
Published: June 2024
|
| 2. |
Biswas M, Ershadian M and Sumasem C
"Clinical incompatibility of CYP2C19 LoF genotype guided clopidogrel against alternative antiplatelets for CAD patients undergoing PCI: Meta-analysis"
28th The Asian Pacific Society of Cardiology Congress (APSC-2024), Dubai International Convention & Exhibition Centre, Dubai, United Arab Emirates.
Published: May 2024
|
| 3. |
Biswas M
"Predictive association of CYP2C9/VKORC1 genetic polymorphisms with bleeding risk of warfarin therapy"
15th ISPE Asian Conference on Pharmacoepidemiology (ACPE15),Bengaluru, India
Published: October 2023
|
| 4. |
Biswas M and Sukasem C
"Impacts of CYP2D6 genetic polymorphisms on the safety or effectiveness of opioids therapy: Systematic review"
9th Association of Southeast Asian Pain Societies (ASEAPS) Congress, Bangkok, Thailand
Published: May 2023
|
| 5. |
Biswas M, Hossain MS, Kali MSK
"Association of CYP2C19 Loss-of-Function Alleles with Clopidogrel induced Adverse Cardiovascular Events in Stroke/Transient Ischemic Attack Patients: An Updated Meta-Analysis."
5th Young Scientist Congress, Dhaka, Bangladesh
Published: November 2022
|
| 6. |
Biswas M
"Global prevalence of CYP2C19 risk phenotypes affecting safety and effectiveness of medications: Implications for clinical practice."
1st International Conference on Drug Discovery and Development (ICDD-2022), Dhaka, Bangladesh
Published: September 2022
|
| 7. |
Biswas M
"Global prevalence of drug metabolizing enzymes and transporter genetic variations: Implications for clinical practice"
The International Conference of the Genetics Society of Thailand 2022 (iGST2022), Bangkok, Thailand.
Published: June 2022
|
| 8. |
Biswas M and Kali MSK
"Effects of CYP2C19 LoF alleles on MACE in Asian stroke patients taking clopidogrel: Meta-analysis"
2nd International Conference on Genomics, Nanotech & Bioengineering-2022 (ICGNB-2022),Dhaka, Bangladesh
Published: June 2022
|
| 9. |
Biswas M
"Genetic variability of CYP2C19 in the world population affecting safety and efficacy of psychiatric medications"
World Congress of Psychiatric Genetics (WCPG), Los Angeles, California, USA
Published: October 2019
|
| 10. |
Biswas M
"Predictive prevalence of CYP2D6 genetic polymorphisms in South Asian women participated in 1000 Genomes Project: Optimizing safety and effectiveness of tamoxifen therapy"
6th Asia Pacific Congress of Interventional Oncology (APCIO), Kuala Lumpur, Malaysia.
Published: October 2019
|
| 11. |
Biswas M
"Global distribution of CYP2C19 genetic polymorphisms affecting safety or efficacy of cardiovascular medications"
International Society on Thrombosis and Haemostasis (ISTH) XXVII Congress, Melbourne, Australia.
Published: July 2019
|
| 12. |
Biswas M
"Predictive prevalence of CYP2C19 genetic polymorphisms in Bangladeshi population affecting safety and effectiveness of medications"
National DNA day conference, University of Rajshahi, Rajshahi, Bangladesh
Published: April 2019
|
| 13. |
Biswas M, Dias TH, Daneshi N et al.
"Preliminary studies of the prevalence and possible clinical consequences of potential simple and multifactorial drug and gene interactions of anti-depressants in older Australians"
International conference on drug discovery and translational medicine 2018 (ICDDTM’18), Putrajaya, Malaysia.
Published: December 2018
|
| 14. |
Biswas M, Dias TH, Daneshi N et al
"Potential simple and multifactorial drug and gene interactions of tricyclic antidepressants in older Australians"
Australasian Pharmaceutical Science Association (APSA)- Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Scientific meeting, Brisbane, Australia
Published: December 2017
|
| 15. |
Biswas M, Dias TH, Daneshi N et al
"Preliminary analysis of potential drug and gene interactions involving tricyclic antidepressant drugs"
5th annual international conferences on pharmacology and pharmaceutical sciences (PHARMA-2017), Singapore
Published: September 2017
|
| 16. |
Biswas M, Daneshi N, Dias TH, Rasiah R, Mate KE Holliday L, et al.
"Prevalence of simple and multifactorial drug gene interactions for cardiovascular drugs in a community cohort of older Australians"
Australian Society for Medical Research (ASMR) National Scientific Conference, Gold Coast, Australia
Published: November 2016
|
| 17. |
Biswas M, Daneshi N, Dias TH, et al
"Prevalence of drug and gene interactions for cardiovascular drugs in older Australians"
Australian Society of Medical Research (ASMR) Scientific Meeting, Sydney, Australia.
Published: June 2016
|
| 18. |
Biswas M, Daneshi N, Rasiah R, et al.
"Prevalence of cytochrome P450 (CYP) substrate-inhibitor interactions in patients on clopidogrel and frequency of CYP2C19*2 gene variants"
Australasian Pharmaceutical Science Association (APSA)- Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Scientific Meeting, Hobart, Australia.
Published: December 2015
|
Not Available
A) Awards, prizes, grants, scholarships and fellowships
- Professional
Achievements and Awards
1) University
of Newcastle International Postgraduate Research Scholarship (UNIPRS) for pursuing
PhD study at the University of Newcastle, Australia, 2014-2018
2) Duncan
Cruickshank Memorial PhD top-up scholarship in Pharmacy from the University of
Newcastle, Australia, 2016-2018
3) Bangladesh
Government National Science Information & Communication Technology (NSICT)
Fellowship for undertaking M. Pharm. thesis, 2009-2010
4) Jashore
Zilla Parishad scholarship for talented students, 2009
5) Rajshahi
University Prize for securing 1st Class and 1st in
cohort in both B. Pharm. (Hons) and M. Pharm.
(Thesis), 2010
6) Rajshahi
University scholarship at graduate level, 2002-2005
7) Junior
talent pool scholarship, Education Board, Government of the People's Republic
of Bangladesh, 1996
8) Primary school scholarship, Directorate of Primary Education, Government of the People's Republic of Bangladesh, 1993
- Conference
Awards
1. Reach
the World travel grant from the International Society on Thrombosis and
Haemostasis (ISTH) to assist with travel, hotel, registration and other
expenses associated with attending the 32ndCongress of the ISTH, June 22–26, 2024, Bangkok, Thailand.
2. Conference
travel grant to assist with travel, hotel and registration from the APSC for
attending 28th The Asian Pacific Society of Cardiology Congress (APSC-2024),
May 2-4, 2024, Dubai International Convention & Exhibition Centre, Dubai,
United Arab Emirates.
3. Conference
scholarship to assist with travel, hotel and registration from the ISPE’s for
attending 15th Asian Conference on Pharmacoepidemiology (ACPE15), October
26-28, 2023, Sheraton Grand Bangalore Hotel at Brigade Gateway, Bengaluru,
India.
4. Early
Career Investigator Programme (ECIP) Travel
Award from the International Society of Psychiatric Genetics (ISPG) to
assist with travel, hotel, registration and other expenses for attending World
Congress of Psychiatric Genetics (WCPG), October 26-31, 2019, Los Angeles,
California, USA.
5. Young
Investigational Research (YIR) grant from Asia Pacific Congress for
Interventional Oncology (APCIO) to assist with registration and accommodation
for attending APCIO conference, October 3-5, 2019, Kuala Lumpur, Malaysia.
6. Reach
the World Travel Grant from the International Society on Thrombosis and
Haemostasis (ISTH) to assist with
travel, hotel, registration and other expenses associated with attending the
XXVII Congress of the ISTH, July 6–10, 2019, Melbourne, Australia.
7. Conference
scholarship from the International Society for Pharmacoepidemiology (ISPE) covering registration fee and social events
for attending 35th ISPE 2019 conference, August 24-28, 2019, USA.
8.
Best Student Research paper award at the 5th annual international conference
on pharmacology and pharmaceutical sciences (PHARMA-2017), September 25-26,
2017, Singapore.
- Other
Achievements and Awards
1) First
position , University of Asia Pacific lecturers chess competition, 2011
2) First
position, selected speech competition “National Education Week” 1996
3) First
position, essay writing competition “National Education Week” 1996
- Professional
Service
1. Treasurer,
Rajshahi University Pharmacy Association, 2014
2. Award
Leader of the Duke of Edinburgh’s International Awards Programme at the
Department of Pharmacy of the University of Asia Pacific, 2010 -2012
3. Sports
Affairs at the Department of Pharmacy of the University of Asia Pacific, 2010
-2012
4. General
Secretary (GS) of Rajshahi University Pharmacy Association (RUPA), 2006
- Professional
memberships
- Clinical
Pharmacogenetics Implementation Consortium (CPIC) life member
- Pharmacogenomics
Research Network (PGRN) life member
- Human
Genome Organization (HUGO) member, 2018-2019
- World
Stroke Organization (WSO) member, 2018-2019
- International
Society for Heart Research (ISHR) member, 2018-2019
- International
Society of Cardiovascular Pharmacotherapy (ISCP) member, 2018-2019
- European
Atherosclerosis Society (EAS) member, 2018-2019
- National
Stroke Associations (NSA) member, 2018-2019
- Society
for Indian Academy of Medical Genetics (SIAMG), Life Associate member
- Australian
Society of Clinical & Experimental Pharmacologists and Toxicologists
(ASCEPT) member, 2015-2016